CRISPR Cas9 Patent Landscape Report
Date: 2022-07-06
How to Use this report:
Use the Table of Contents below to navigate to specific sections by clicking on the headings.
The HTML version of this report provides interactive figures and tables, with mouse-over, zoomable data display, and searchable, sortable tables. This provides the user with the capability to further explore the landscaping results.
This report is updated on an as-needed basis.
Table of Contents:
Overview:
The PatSnap Connected Innovation Intelligence platform was used to execute this patent landscape analysis. PatSnap’s semantic search capability was used to generate the domain collection by executing 28 separate semantic queries using each of the documents named in the February 28th USPTO PTAB Interference decision. Each semantic query yields up to 1,000 of the most semantically similar patent documents. These queries were first executed as two subdomains and stored as separate workspaces within PatSnap. The first was for the 14 documents from the Berkeley group, which consists of the University of California Berkeley, the University of Vienna, and scientist Emmanuelle Charpentier, who was formerly associated with the University of Vienna, collectively referred to as “CVC” in the Interference decision. The second subdomain consists of the 14 documents from the Broad Institute group, consisting of The Broad Institute, the Massachusetts Institute of Technology, and Harvard University, collectively referred to as “Broad” in the Interference decision. These subdomains were then combined into a single workspace so that the results of the 28 semantic queries were aggregated into a final domain collection for analysis. As the query results and subdomains are combined into a single workspace, duplicate patent documents are deleted automatically by the PatSnap tool. For the 14 patent documents assigned to the CVC group, this process resulted in a subdomain collection of 1,382 patent documents consisting of 373 simple patent families. For the 14 patent documents assigned to the Broad Institute group, this process resulted in a subdomain of 2,967 patent documents consisting of 757 simple families. Combing the two subdomains to produce the final domain collection resulted in a workspace with 3,455 patent documents consisting of 859 simple patent families. The patent document landscaping analysis was performed on this workspace.
- This is a summary table of the fundamental CRISPR patent documents that have been used as seeds in semantic queries to create the domain collection.
- These are the 28 patent documents named in the February 28, 2022 USPTO PTAB Interference Proceeding.
- Click on column headings to sort.
- Use the Search boxes to search on any column.
Index | Patent or Application # | Entity | Google Publication Number Linked | Title | Application Filing Date | Priority To | Earliest Priority Date |
---|---|---|---|---|---|---|---|
0 | 15/947,680 | CVC | US20180230495A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 4/6/2018 | US201261652086P, and others. | 5/25/2012 |
1 | 15/947,700 | CVC | US20180230496A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 4/6/2018 | US201261652086P, and others. | 5/25/2012 |
2 | 15/947,718 | CVC | US20180230497A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 4/6/2018 | US201261652086P, and others. | 5/25/2012 |
3 | 15/981,807 | CVC | US20180251793A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 5/16/2018 | US201261652086P, and others. | 5/25/2012 |
4 | 15/981,808 | CVC | US20180251794A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 5/16/2018 | US201261652086P, and others. | 5/25/2012 |
5 | 15/981,809 | CVC | US20180251795A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 5/16/2018 | US201261652086P, and others. | 5/25/2012 |
6 | 16/136,159 | CVC | US20190002921A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 9/19/2018 | US201261652086P, and others. | 5/25/2012 |
7 | 16/136,165 | CVC | US20190002922A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 9/19/2018 | US201261652086P, and others. | 5/25/2012 |
8 | 16/136,168 | CVC | US20190002923A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 9/19/2018 | US201261652086P, and others. | 5/25/2012 |
9 | 16/136,175 | CVC | US20190010520A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 9/19/2018 | US201261652086P, and others. | 5/25/2012 |
10 | 16/276,361 | CVC | US20190169645A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 2/14/2019 | US201261652086P, and others. | 5/25/2012 |
11 | 16/276,365 | CVC | US20190169646A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 2/14/2019 | US201261652086P, and others. | 5/25/2012 |
12 | 16/276,368 | CVC | US20190169647A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 2/14/2019 | US201261652086P, and others. | 5/25/2012 |
13 | 16/276,374 | CVC | US20190169648A1 | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | 2/14/2019 | US201261652086P, and others. | 5/25/2012 |
14 | 8,697,359 | Broad | US8697359B1 | CRISPR-Cas systems and methods for altering expression of gene products | 10/15/2013 | US201261736527P, and others. | 12/12/2012 |
15 | 8,771,945 | Broad | US8771945B1 | CRISPR-Cas systems and methods for altering expression of gene products | 2/18/2014 | US201261736527P, and others. | 12/12/2012 |
16 | 8,795,965 | Broad | US8795965B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | 2/18/2014 | US201261736527P, and others. | 12/12/2012 |
17 | 8,865,406 | Broad | US8865406B2 | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation | 3/24/2014 | US201261736527P, and others. | 12/12/2012 |
18 | 8,871,445 | Broad | US8871445B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | 4/23/2014 | US201261736527P, and others. | 12/12/2012 |
19 | 8,889,356 | Broad | US8889356B2 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | 2/18/2014 | US201261736527P, and others. | 12/12/2012 |
20 | 8,895,308 | Broad | US8895308B1 | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation | 6/2/2014 | US201261736527P, and others. | 12/12/2012 |
21 | 8,906,616 | Broad | US8906616B2 | Engineering of systems, methods and optimized guide compositions for sequence manipulation | 5/29/2014 | US201261736527P, and others. | 12/12/2012 |
22 | 8,932,814 | Broad | US8932814B2 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | 4/22/2014 | US201261736527P, and others. | 12/12/2012 |
23 | 8,945,839 | Broad | US8945839B2 | CRISPR-Cas systems and methods for altering expression of gene products | 4/18/2014 | US201261736527P, and others. | 12/12/2012 |
24 | 8,993,233 | Broad | US8993233B2 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | 12/12/2013 | US201261736527P, and others. | 12/12/2012 |
25 | 8,999,641 | Broad | US8999641B2 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | 3/26/2014 | US201261736527P, and others. | 12/12/2012 |
26 | 9,840,713 | Broad | US9840713B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | 10/24/2014 | US201261736527P, and others. | 12/12/2012 |
27 | 14/704,551 | Broad | US20150247150A1 | Engineering of systems, methods and optimized guide compositions for sequence manipulation | 5/5/2015 | US201261736527P, and others. | 12/12/2012 |
- This is a summary table of the all the patent documents in the domain collection. The domain collection consists of 3,455 patent documents consisting of 859 simple patent families.
- Many of these documents could be duplicates of the same patent application or granted patent in different countries.
- Click on column headings to sort.
- Use the Search boxes to search on any column.
Index | Publication Date | Application Date | Issue Date | Application Number | Publication Number | Simple Family | Current Assignee Country | Title | Abstract (Translated) | Claims | Standardized Current Assignee | PatSnap Publication Number Linked | Google Publication Number Linked |
---|
- This is a summary table of the top current assignee countries and tabulates the countries of assignees across all grouped patent families in the domain collection.
- This table is designed to show the geographic concentrations of the owners of the intellectual property.
- For the CRISPR domain collection this is indicating that the assignees of the fundamental IP largely reside in the United States, which is not unexpected given that the initial patent filings in this IP sector were by the Berkeley group and the Broad Institute group.
- This is a summary table of the simple legal status of the patent documents in the domain collection and presents the data corresponding to the filing stages of the documents.
- The PCT (Patent Cooperation Treaty) classifications refer to the initial filing stages of internationally designated patent applications.
- The Pending classification refers to applications that are pending in national stage examinations.
- Active classification refers to granted patents.
- This chart is often useful in providing insight into the maturity of an IP sector.
- For the CRISPR domain collection, it is indicating that it’s still early in the evolution of this IP sector as 45% of the patent families are still in pending stage and only approximately 20% have been granted.
- The applications and granted patents timeline provides a concise view of the historic trends of patenting activity embodied in the domain collection.
- The chart shows the number of granted patents resulting from applications filed in the same year.
- This is helpful for understanding the application filing rate as well as the grant rate for the IP sector. The application filing rate can be an indicator of the IP competitive landscape and the grant rate can an indicator of the approval environment.
- Also note that the most recent data (the most recent ~18-24 months) is likely only partial data, as there are publishing delays and sometimes long pendency times (time between application and grant approval) associated with various patent jurisdictions.
- For the CRISPR domain collection the increasing application numbers and the decreasing grant rate both indicate an increasingly competitive environment with more applications being filed and fewer granted patents being allowed on a percentage basis. The current grant rate for this IP sector is approximately 10%.
- This shows the top 100 inventors for the CRISPR domain collection and essentially lists the individuals who are the top intellectual property experts.
- For the CRISPR domain collection this list is led by individuals associated with the Broad Institute group and the Berkeley group.
- Click on column headings to sort.
- Use the Search boxes to search on any column.
Index | Inventor Name | Number of Patent Documents |
---|---|---|
0 | ZHANG, FENG | 78 |
1 | CHURCH, GEORGE M. | 21 |
2 | DOUDNA, JENNIFER A. | 20 |
3 | ZETSCHE, BERND | 14 |
4 | RAN, FEI | 13 |
5 | BARRANGOU, RODOLPHE | 12 |
6 | 王帅 | 11 |
7 | 王永明 | 11 |
8 | 胡子英 | 11 |
9 | CONG, LE | 10 |
10 | JOUNG, J. KEITH | 10 |
11 | 王大奇 | 10 |
12 | FRISCH, RYAN L. | 9 |
13 | MAY, ANDREW PAUL | 9 |
14 | BANFIELD, JILLIAN F. | 8 |
15 | COX, DAVID BENJAMIN TURITZ | 8 |
16 | CRAWLEY, ALEXANDRA BRINER | 8 |
17 | SCOTT, DAVID A. | 8 |
18 | URNOV, FYODOR | 8 |
19 | ABUDAYYEH, OMAR O. | 7 |
20 | ALTAE-TRAN, HAN | 7 |
21 | CHENG, DAVID R. | 7 |
22 | CHOUDHARY, AMIT | 7 |
23 | CIGAN, ANDREW MARK | 7 |
24 | DUCHATEAU, PHILIPPE | 7 |
25 | GARST, ANDREW | 7 |
26 | KHALILI, KAMEL | 7 |
27 | KIANI, SAMIRA | 7 |
28 | KONERMANN, SILVANA | 7 |
29 | ROUBOS, JOHANNES ANDRIES | 7 |
30 | YAN, WINSTON X. | 7 |
31 | YOUNG, JOSHUA K. | 7 |
32 | DAVIS, GREGORY D. | 6 |
33 | DONOHOUE, PAUL DANIEL | 6 |
34 | GILL, RYAN T. | 6 |
35 | GOOTENBERG, JONATHAN | 6 |
36 | HEIDENREICH, MATTHIAS | 6 |
37 | HSU, PATRICK | 6 |
38 | KLEINSTIVER, BENJAMIN | 6 |
39 | LIU, DAVID R. | 6 |
40 | LIU, DAVID, R. | 6 |
41 | NISHIDA, KEIJI | 6 |
42 | PLATT, RANDALL JEFFREY | 6 |
43 | SANJANA, NEVILLE ESPI | 6 |
44 | SLAYMAKER, IAN | 6 |
45 | VAN DER OOST, JOHN | 6 |
46 | YANG, LUHAN | 6 |
47 | ALEXANDER, LISA | 5 |
48 | ANDERSON, DANIEL G. | 5 |
49 | BROWN, CHRISTOPHER | 5 |
50 | BURSTEIN, DAVID | 5 |
51 | BUTTERFIELD, CRISTINA | 5 |
52 | CHAVEZ, ALEJANDRO | 5 |
53 | CHEN, FUQIANG | 5 |
54 | DEVOTO, AUDRA | 5 |
55 | GREGORY, PHILIP D. | 5 |
56 | HARRINGTON, LUCAS BENJAMIN | 5 |
57 | HOLMES, MICHAEL C. | 5 |
58 | JANTZ, DEREK | 5 |
59 | KONDO, AKIHIKO | 5 |
60 | LUNDBERG, ANTE SVEN | 5 |
61 | MALI, PRASHANT G. | 5 |
62 | SHALEM, OPHIR | 5 |
63 | SMITH, JAMES JEFFERSON | 5 |
64 | THOMAS, BRIAN | 5 |
65 | VERWAAL, RENÉ | 5 |
66 | WANG, JIANBIN | 5 |
67 | YIN, HAO | 5 |
68 | ZAMBROWICZ, BRIAN | 5 |
69 | AUERBACH, WOJTEK | 4 |
70 | BARAM, DAVID | 4 |
71 | BAUER, DANIEL E. | 4 |
72 | BLAINEY, PAUL | 4 |
73 | BOWEN, TYSON D. | 4 |
74 | CHOUDHURY, SOURAV | 4 |
75 | COCO, WAYNE | 4 |
76 | COHNEN, ANDRE | 4 |
77 | COST, GREGORY J. | 4 |
78 | COYLE, MICHAEL | 4 |
79 | DAHLMAN, JAMES E. | 4 |
80 | EBRAHIMKHANI, MO REZA | 4 |
81 | ELICH, TEDD D. | 4 |
82 | ESVELT, KEVIN M. | 4 |
83 | FAN, XIAOCHUN | 4 |
84 | FRENDEWEY, DAVID | 4 |
85 | GERSBACH, CHARLES A. | 4 |
86 | GERSBACH, CHARLES, A. | 4 |
87 | GIELESEN, BIANCA ELISABETH MARIA | 4 |
88 | HONG, SEUNG-PYO | 4 |
89 | HOU, ZHENGLIN | 4 |
90 | HUMMEL, AARON | 4 |
91 | IZHAR, LIOR | 4 |
92 | KANNAN, SOUMYA | 4 |
93 | KANTOR, ROSE | 4 |
94 | KARVELIS, TAUTVYDAS | 4 |
95 | KING, MATTHEW G. | 4 |
96 | KONG, LING-JIE | 4 |
97 | LAWIT, SHAI JOSHUA | 4 |
98 | LIN, CHIE-YU | 4 |
99 | LIN, HAINING | 4 |
- This shows the top 100 standardized current assignees. The standardization of assignees in this list is a process within PatSnap where assignees and tabulations of patent documents are aggregated to account for M&A transactions and situations where an assignee is a division of a parent corporation.
- Click on column headings to sort.
- Use the Search boxes to search on any column.
Index | Standardized Current Assignee | Number of Patent Documents |
---|---|---|
0 | MASSACHUSETTS INST OF TECH | 111 |
1 | BROAD INSTITUTE | 103 |
2 | PRESIDENT & FELLOWS OF HARVARD COLLEGE | 78 |
3 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 45 |
4 | SANGAMO BIOSCIENCES INC | 17 |
5 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV | 16 |
6 | CRISPR THERAPEUTICS AG | 15 |
7 | NORTH CAROLINA STATE UNIVERSITY | 15 |
8 | PIONEER HI-BRED INT INC | 13 |
9 | THE GENERAL HOSPITAL CORP | 13 |
10 | DUKE UNIV | 12 |
11 | THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK | 12 |
12 | CARIBOU BIOSCI | 12 |
13 | FUDAN UNIV | 11 |
14 | SIGMA ALDRICH CO LLC | 11 |
15 | CHILDRENS MEDICAL CENT CORP | 10 |
16 | UNIV OF MASSACHUSETTS | 10 |
17 | THE BRIGHAM & WOMENS HOSPITAL INC | 10 |
18 | INSCRIPTA INC | 9 |
19 | REGENERON PHARM INC | 9 |
20 | EDITAS MEDICINE | 9 |
21 | ARBOR BIOTECH INC | 9 |
22 | THE TRUSTEES OF THE UNIV OF PENNSYLVANIA | 8 |
23 | ROCKEFELLER UNIV THE | 8 |
24 | TEMPLE UNIVERSITY | 8 |
25 | DSM IP ASSETS BV | 7 |
26 | ARIZONA STATE UNIVERSITY | 7 |
27 | TOOLGEN | 7 |
28 | DANISCO US INC | 7 |
29 | CELLECTIS SA | 7 |
30 | PAIRWISE PLANTS SERVICES INC | 6 |
31 | THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE | 6 |
32 | WHITEHEAD INST FOR BIOMEDICAL RES | 6 |
33 | PRECISION BIOSCI | 6 |
34 | AGILENT TECH INC | 6 |
35 | KOBE UNIVERSITY | 6 |
36 | UNIV OF WASHINGTON | 6 |
37 | WAGENINGEN UNIV | 5 |
38 | VERTEX PHARMA INC | 5 |
39 | EMENDOBIO INC | 5 |
40 | RUTGERS UNIVERSITY | 5 |
41 | BRAIN AG | 5 |
42 | RGT UNIV OF MINNESOTA | 4 |
43 | INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) | 4 |
44 | BAYER HEALTHCARE LLC | 4 |
45 | CENT NAT DE LA RECHERCHE SCI | 4 |
46 | UNIV OF COLORADO THE REGENTS OF | 4 |
47 | MONSANTO TECH LLC | 4 |
48 | LIFEEDIT INC | 4 |
49 | DUPONT US HLDG LLC | 4 |
50 | INST FOR BASIC SCI | 3 |
51 | UNIV OF SOUTHERN CALIFORNIA | 3 |
52 | INTEGRATED DNA TECHNOLOGIES | 3 |
53 | CHRISTIANA CARE HEALTH SERVICES | 3 |
54 | IZHAR LIOR | 3 |
55 | TECHNICAL UNIVERSITY OF DENMARK | 3 |
56 | SUN YAT-SEN UNIV | 3 |
57 | INARI AGRI INC | 3 |
58 | NOVOZYMES AS | 3 |
59 | APPL STEMCELL INC | 3 |
60 | US DEPT OF HEALTH | 3 |
61 | WISCONSIN ALUMNI RES FOUNDATION | 3 |
62 | ASTRAZENECA AB | 3 |
63 | JACKSON LABORATORY | 3 |
64 | OHIO STATE INNOVATION FOUND | 3 |
65 | QINGDAO AGRI UNIV | 3 |
66 | METAGENOMI INC | 3 |
67 | THE UNIV OF TOKYO | 3 |
68 | DEUTES KREBSFORSCHUNGSZENT STIFTUNG DES OFFENTLICHEN RECHTS | 3 |
69 | ZYMERGEN INC | 3 |
70 | BARAM DAVID | 3 |
71 | KATHOLIEKE UNIVERSITEIT LEUVEN | 3 |
72 | METAGENOMI IP TECH LLC | 3 |
73 | INTELLIA THERAPEUTICS INC | 3 |
74 | PEIKING UNIVERSITY | 3 |
75 | INST OF ZOOLOGY CHINESE ACAD OF SCI | 3 |
76 | EMORY UNIVERSITY | 3 |
77 | THE UNIV OF NORTH CAROLINA AT CHAPEL HILL | 3 |
78 | MONTANA STATE UNIVERSITY | 3 |
79 | THE CHILDRENS HOSPITAL OF PHILADELPHIA | 2 |
80 | UNIV OF MARYLAND | 2 |
81 | CHINA AGRI UNIV | 2 |
82 | UNIV OF IOWA RES FOUND | 2 |
83 | THE CHINESE UNIVERSITY OF HONG KONG | 2 |
84 | AVELLINO LAB USA | 2 |
85 | THE CATHOLIC UNIVERSITY OF AMERICA | 2 |
86 | OSAKA UNIV | 2 |
87 | DIAMANT NOAM | 2 |
88 | ALLEN INST | 2 |
89 | YALE UNIV | 2 |
90 | BANFIELD JILLIAN F | 2 |
91 | UNIVERSITY OF HEIDELBERG | 2 |
92 | CHAN ZUCKERBERG BIOHUB INC | 2 |
93 | LARIX BIOSCI | 2 |
94 | IOWA STATE UNIV RES FOUND | 2 |
95 | ETH ZZURICH | 2 |
96 | LEXICON PHARM INC | 2 |
97 | NOVARTIS AG | 2 |
98 | THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS | 2 |
99 | STICHTING VOOR DE TECH WETENSCHAPPEN | 2 |
- This shows the most cited patent documents across all the documents in the domain collection and can help identify foundational prior art and important patent references as well as additional IP competitors (assignees) in the sector.
- A cited patent document is typically a patent application or granted patent that is considered significant (prior art, or in some way relevant) to the patent application that cites it.
- The table below thus represents the list of the top 50 most cited patent document references on granted patents and patent applications in the CRISPR domain collection.
- Click on column headings to sort.
- Use the Search boxes to search on any column.
Index | PatSnap Publication Number Linked | Google Publication Number Linked | Title | Application Date | Publication Date | Standardized Current Assignee | Count of Cited by Patents |
---|---|---|---|---|---|---|---|
0 | WO2013141680A1 | WO2013141680A1 | RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX | 2013-03-15 | 2013-09-26 | VILNIUS UNIVERSITY | 440 |
1 | US20110207221A1 | US20110207221A1 | Targeted genomic modification with partially single-stranded donor molecules | 2011-02-09 | 2011-08-25 | SANGAMO BIOSCIENCES INC | 371 |
2 | US20150098954A1 | US20150098954A1 | Compositions and Methods Related to CRISPR Targeting | 2013-10-08 | 2015-04-09 | ELWHA LLC | 200 |
3 | WO2014093479A1 | WO2014093479A1 | Crispr (clustered regularly interspaced short palindromic repeats) RNA-guided control of gene regulation | 2013-12-11 | 2014-06-19 | MONTANA STATE UNIVERSITY | 178 |
4 | US10017760B2 | US10017760B2 | Methods for generating barcoded combinatorial libraries | 2017-06-23 | 2018-07-10 | UNIV OF COLORADO THE REGENTS OF | INSCRIPTA INC | 145 |
5 | US20160168592A1 | US20160168592A1 | Multiplex RNA-Guided Genome Engineering | 2014-07-08 | 2016-06-16 | PRESIDENT & FELLOWS OF HARVARD COLLEGE | 140 |
6 | US20150044772A1 | US20150044772A1 | Crispr/cas system-based novel fusion protein and its applications in genome editing | 2014-08-08 | 2015-02-12 | SAGE LABS | 136 |
7 | US20150291965A1 | US20150291965A1 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | 2015-06-12 | 2015-10-15 | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | PRESIDENT & FELLOWS OF HARVARD COLLEGE | 135 |
8 | US20150024499A1 | US20150024499A1 | Modified cascade ribonucleoproteins and uses thereof | 2014-07-08 | 2015-01-22 | CARIBOU BIOSCI | 135 |
9 | US20160289673A1 | US20160289673A1 | Optimized small guide rnas and methods of use | 2014-09-29 | 2016-10-06 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 125 |
10 | WO2012088381A2 | WO2012088381A2 | Continuous directed evolution | 2011-12-22 | 2012-06-28 | PRESIDENT & FELLOWS OF HARVARD COLLEGE | LIU DAVID R | ESVELT KEVIN M | CARLSON JACOB CHARLES | 120 |
11 | US20140349405A1 | US20140349405A1 | Rna-directed DNA cleavage and gene editing by cas9 enzyme from neisseria meningitidis | 2014-05-22 | 2014-11-27 | WISCONSIN ALUMNI RES FOUNDATION | NORTHWESTERN UNIV | 117 |
12 | US20160340662A1 | US20160340662A1 | Engineering of systems, methods and optimized guide compositions for sequence manipulation | 2016-08-05 | 2016-11-24 | PRESIDENT & FELLOWS OF HARVARD COLLEGE | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | 107 |
13 | US20150191744A1 | US20150191744A1 | Cas9 effector-mediated regulation of transcription, differentiation and gene editing/labeling | 2014-12-16 | 2015-07-09 | UNIV OF CENT FLORIDA RES FOUND INC | UNIV OF MASSACHUSETTS | 89 |
14 | US20170022499A1 | US20170022499A1 | Methods and compositions for the production of guide RNA | 2015-04-03 | 2017-01-26 | MASSACHUSETTS INST OF TECH | 81 |
15 | WO2014194190A1 | WO2014194190A1 | Gene targeting and genetic modification of plants via RNA-guided genome editing | 2014-05-30 | 2014-12-04 | PENN STATE RES FOUND | 80 |
16 | US20160153004A1 | US20160153004A1 | Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells | 2015-12-16 | 2016-06-02 | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | 76 |
17 | US20170029805A1 | US20170029805A1 | Methods and compositions for modifying genomic DNA | 2015-04-13 | 2017-02-02 | MAXCYTE | 73 |
18 | US20170198269A1 | US20170198269A1 | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation | 2016-11-07 | 2017-07-13 | PRESIDENT & FELLOWS OF HARVARD COLLEGE | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | 72 |
19 | US6207371B1 | US6207371B1 | Indexed library of cells containing genomic modifications and methods of making and utilizing the same | 1997-10-02 | 2001-03-27 | LEXICON PHARM INC | 65 |
20 | WO2016115355A1 | WO2016115355A1 | RNA guided eradication of herpes simplex type i and other related herpesviruses | 2016-01-14 | 2016-07-21 | TEMPLE UNIVERSITY | 61 |
21 | US20160298096A1 | US20160298096A1 | Crispr-cas system materials and methods | 2014-11-17 | 2016-10-13 | CRISPR THERAPEUTICS AG | 60 |
22 | WO2017127807A1 | WO2017127807A1 | Crystal structure of crispr cpf1 | 2017-01-23 | 2017-07-27 | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | THE UNIV OF TOKYO | US DEPT OF HEALTH | YAMANO TAKASHI | NISHIMASU HIROSHI | ZETSCHE BERND | SLAYMAKER IAN | LI YINQING | FEDOROVA IANA | MAKAROVA KIRA | GAO LINYI | KOONIN EUGENE | ZHANG FENG | NUREKI OSAMU | 60 |
23 | US9822370B2 | US9822370B2 | Method of making a deletion in a target sequence in isolated primary cells using Cas9 and two guide RNAs | 2014-09-12 | 2017-11-21 | PRESIDENT & FELLOWS OF HARVARD COLLEGE | CHILDRENS MEDICAL CENT CORP | 58 |
24 | WO2017015015A1 | WO2017015015A1 | Crispr-associated protein from francisella and uses related thereto | 2016-07-13 | 2017-01-26 | EMORY UNIVERSITY | 56 |
25 | US20150110762A1 | US20150110762A1 | Delivery methods and compositions for nuclease-mediated genome engineering | 2014-10-16 | 2015-04-23 | SANGAMO BIOSCIENCES INC | 54 |
26 | US20180135073A1 | US20180135073A1 | Crispr-based genome modification and regulation | 2017-07-18 | 2018-05-17 | SIGMA ALDRICH CO LLC | 53 |
27 | WO2018213708A1 | WO2018213708A1 | Systems, methods, and compositions for targeted nucleic acid editing | 2018-05-18 | 2018-11-22 | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | PRESIDENT & FELLOWS OF HARVARD COLLEGE | 52 |
28 | US20170198302A1 | US20170198302A1 | Methods and systems for targeted gene manipulation | 2016-11-17 | 2017-07-13 | THE CHINESE UNIVERSITY OF HONG KONG | 51 |
29 | US20150315576A1 | US20150315576A1 | Genetic device for the controlled destruction of DNA | 2013-11-01 | 2015-11-05 | MASSACHUSETTS INST OF TECH | 50 |
30 | WO2016176191A1 | WO2016176191A1 | Dual aav vector system for crispr/cas9 mediated correction of human disease | 2016-04-26 | 2016-11-03 | THE TRUSTEES OF THE UNIV OF PENNSYLVANIA | 45 |
31 | US20160340661A1 | US20160340661A1 | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing | 2016-06-10 | 2016-11-24 | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | 41 |
32 | US20160102324A1 | US20160102324A1 | New compact scaffold of cas9 in the type ii crispr system | 2014-05-28 | 2016-04-14 | CELLECTIS SA | 37 |
33 | WO2018074979A1 | WO2018074979A1 | Truncated crispr-cas proteins for DNA targeting | 2017-10-17 | 2018-04-26 | NANYANG TECH UNIV | AGENCY FOR SCI TECH & RES | 37 |
34 | WO2019005886A1 | WO2019005886A1 | Crispr/cas-cytidine deaminase based compositions, systems, and methods for targeted nucleic acid editing | 2018-06-26 | 2019-01-03 | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | PRESIDENT & FELLOWS OF HARVARD COLLEGE | KANNAN SOUMYA | 37 |
35 | WO2016097751A1 | WO2016097751A1 | Method of cas9 mediated genome engineering | 2015-12-18 | 2016-06-23 | UNIVERSITY OF BATH | 36 |
36 | WO2016069910A1 | WO2016069910A1 | Methods for efficient delivery of therapeutic molecules in vitro and in vivo | 2015-10-29 | 2016-05-06 | MASSACHUSETTS EYE & EAR INFARY | 35 |
37 | US20160324938A1 | US20160324938A1 | Sequence specific antimicrobials | 2016-05-20 | 2016-11-10 | ROCKEFELLER UNIV THE | 35 |
38 | US20170020922A1 | US20170020922A1 | Gene editing for immunological destruction of neoplasia | 2016-07-06 | 2017-01-26 | BATU BIOLOGICS | 35 |
39 | WO2015127428A1 | WO2015127428A1 | Methods for in vivo genome editing | 2015-02-24 | 2015-08-27 | MASSACHUSETTS INST OF TECH | 34 |
40 | WO2016070070A1 | WO2016070070A1 | RNA guided eradication of human jc virus and other polyomaviruses | 2015-10-30 | 2016-05-06 | TEMPLE UNIVERSITY | 34 |
41 | WO2016182893A1 | WO2016182893A1 | Functional genomics using crispr-cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereof | 2016-05-06 | 2016-11-17 | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | CHILDRENS MEDICAL CENT CORP | 33 |
42 | US20170058272A1 | US20170058272A1 | Directed nucleic acid repair | 2016-08-31 | 2017-03-02 | CARIBOU BIOSCI | 32 |
43 | US7361641B2 | US7361641B2 | Methods and compositions for genomic modification | 2003-08-05 | 2008-04-22 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV | 31 |
44 | WO2017189336A1 | WO2017189336A1 | Methods and compositions for genomic editing | 2017-04-20 | 2017-11-02 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 31 |
45 | WO2017024047A1 | WO2017024047A1 | Compositions and methods for increasing nuclease induced recombination rate in cells | 2016-08-03 | 2017-02-09 | EMENDOBIO INC | IZHAR LIOR | BARAM DAVID | DIAMANT NOAM | 28 |
46 | WO2017123609A1 | WO2017123609A1 | Compositions and methods for enhanced genome editing | 2017-01-11 | 2017-07-20 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 28 |
47 | WO2017161068A1 | WO2017161068A1 | Mutant cas proteins | 2017-03-16 | 2017-09-21 | PRESIDENT & FELLOWS OF HARVARD COLLEGE | 27 |
48 | WO2017040786A1 | WO2017040786A1 | Multilayer genetic safety kill circuits based on single cas9 protein and multiple engineered grna in mammalian cells | 2016-09-01 | 2017-03-09 | MASSACHUSETTS INST OF TECH | 26 |
49 | WO1999007389A1 | WO1999007389A1 | Targeted gene discovery | 1998-08-06 | 1999-02-18 | LEXICON PHARM INC | 26 |
- Patent document technology classification codes are often utilized to gain insight into the technology applied in an IP sector or domain collection by analyzing the patent document information, the assigned class codes, and the description of those class codes.
- Classification codes are assigned to every patent document to categorize the inventive ideas. Patent documents can be assigned multiple classification codes representing each potentially different inventive idea embodied in the patent filing.
- The tables below show the break-down of the technology classification codes as applied to the patent documents of the top assignees. The first table shows the top five classification codes applied to all patent documents in the domain collection as well as the corresponding descriptions. The second table then shows the tabulation of the top five class codes as applied to the patent documents of the top 10 assignees.
- In a general sense this shows the broader areas of focus for those top assignees.
- Patent landscape diagramming is a versatile technique that can be used to visualize and explore a patent document domain collection.
- The main landscape diagram is generated via natural language processing (NPL) and semantically similar text clustering of the patent documents in the domain collection. A topographical diagram is generated using all the documents of the domain collection with topographical peaks representing higher concentrations of patent documents and troughs representing areas with lower concentrations or no patent documents at all. Textbox callouts are then generated for the higher concentrations and significantly differentiated text clusters.
- The diagram below shows the topographical landscape diagram created from the 3,455 ungrouped patent documents of the CRISPR domain collection. Textbox callouts have been automatically added for the NLP-derived clusters of patent documents. Red and yellow dots have been added to the diagram that represent the patent documents assigned to the entities of the Berkeley group (yellow dots) and the Broad Institute group (red dots). This visualization shows how the semantic analysis algorithm has differentiated the focus areas of the two research organizations, with the Berkeley group patent documents mostly in the upper-left corner of the diagram and the Broad Institute group documents in the lower-left corner.